Elutia(ELUT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ELUT Elutia

休市中 09-11 16:00:00 EDT

0.8100

+0.0098

+1.22%

盘后0.8100

+0.00000.00%

18:11 EDT

最高0.8280	最低0.7700	成交量2.50万
今开0.8170	昨收0.8002	日振幅7.25%
总市值3,581万	流通市值2,385万	总股本4,421万
成交额2.00万	换手率0.08%	流通股本2,944万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ELUT","market":"US","secType":"STK","nameCN":"Elutia","latestPrice":0.81,"timestamp":1789156800000,"preClose":0.8002,"halted":0,"volume":25017,"hourTrading":{"tag":"盘后","latestPrice":0.81,"preClose":0.81,"latestTime":"18:11 EDT","volume":8,"amount":6.471718,"timestamp":1789164693372,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.012246938265433679,"floatShares":29443400,"shares":44208200,"eps":1.005905,"marketStatus":"休市中","change":0.0098,"latestTime":"09-11 16:00:00 EDT","open":0.817,"high":0.828,"low":0.77,"amount":19999.5979851,"amplitude":0.072482,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.005905,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1602129600000,"exchange":"NASDAQ","adjPreClose":0.8002,"postHourTrading":{"tag":"盘后","latestPrice":0.81,"preClose":0.81,"latestTime":"18:11 EDT","volume":8,"amount":6.471718,"timestamp":1789164693372,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9215382955974729},"requestUrl":"/m/hq/s/ELUT","defaultTab":"news","newsList":[{"id":"1101962173","title":"Elutia获得高达2600万美元融资，助力NXT-41X商业化上市；同步公布2026年第二季度财报","url":"https://stock-news.laohu8.com/highlight/detail?id=1101962173","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101962173?lang=zh_cn&edition=full","pubTime":"2026-08-14 04:10","pubTimestamp":1786651840,"startTime":"0","endTime":"0","summary":"Elutia成功筹集了高达2600万美元的资金，这笔资金将用于推动其核心产品NXT-41X直至商业化上市。与此同时，公司也正式对外披露了2026年第二季度的财务业绩。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143030921","title":"Elutia获Avenue Capital Group 1500万美元贷款，助力NXT-41X进军15亿美元整形与重建外科市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1143030921","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143030921?lang=zh_cn&edition=full","pubTime":"2026-08-14 04:06","pubTimestamp":1786651595,"startTime":"0","endTime":"0","summary":"Elutia成功从Avenue Capital Group获得一笔1500万美元的贷款融资。这笔资金将专门用于推动其旗下产品NXT-41X的上市计划。该产品瞄准的领域，是规模高达15亿美元的整形与重建外科市场。这一举措，无疑为Elutia在激烈的市场竞争中注入了强劲动力。通过这项融资，公司得以加速推进商业化进程，力求在高端医疗设备领域占据一席之地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113781515","title":"Elutia签署最终协议，以高达1100万美元交易价值出售Simpliderm®，为NXT-41X上市前强化资产负债表","url":"https://stock-news.laohu8.com/highlight/detail?id=1113781515","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113781515?lang=zh_cn&edition=full","pubTime":"2026-07-17 04:06","pubTimestamp":1784232374,"startTime":"0","endTime":"0","summary":"Elutia已签署一项最终协议，将出售其Simpliderm®产品线。这笔交易的总价值最高可达1100万美元。此举旨在公司即将推出NXT-41X产品之前，显著增强其资产负债表实力。\n此次资产剥离预计将为Elutia带来重要的非稀释性资金，优化公司的资本结构。通过出售Simpliderm®，Elutia能够更加专注于其核心产品线的研发与商业化进程，特别是为NXT-41X的未来市场推出做好更充分的财务准备。这一战略决策有助于公司集中资源，把握关键增长机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152702590","title":"Elutia公布2026年第一季度财报，并强调NXT-41X在进军150亿美元美国整形与重建外科市场方面取得进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1152702590","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152702590?lang=zh_cn&edition=full","pubTime":"2026-05-15 04:05","pubTimestamp":1778789155,"startTime":"0","endTime":"0","summary":"Elutia发布了其2026年第一季度的财务业绩，同时重点展示了其核心产品NXT-41X的研发与市场推进情况，目标直指规模高达150亿美元的美国整形与重建外科市场。\n财报数据显示了公司在当季的运营表现与财务健康状况。与此同时，公司着重强调了NXT-41X项目所取得的积极进展，该产品被视为公司未来增长的关键驱动力，旨在从庞大的美国整形外科市场中分得一杯羹。\n管理层对NXT-41X的商业化前景表达了信心，认为其有潜力满足市场未满足的临床需求。公司正持续推进相关临床开发与监管申报工作，以期在这一高价值市场领域确立竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103525572","title":"TELA Bio董事会高层变动：主席道格·埃文斯及三名董事库尔特·阿扎巴津、文斯·伯吉斯、费德里卡·奥布莱恩将离任","url":"https://stock-news.laohu8.com/highlight/detail?id=1103525572","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103525572?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:45","pubTimestamp":1777581942,"startTime":"0","endTime":"0","summary":"医疗技术公司TELA Bio, Inc.宣布其董事会将迎来重大人事调整。公司现任董事会主席道格·埃文斯已决定辞去主席及董事职务。与此同时，库尔特·阿扎巴津、文斯·伯吉斯以及费德里卡·奥布莱恩三位董事也将一同离开董事会。\n此次多位核心董事的集中离任，标志着TELA Bio公司治理结构进入一个关键过渡期。公司未来的战略方向与领导层构成备受市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","ELUT","AXGN","BK4139","ANIK","MDXG","BK4198","BK4082","BVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110396189","title":"TELA Bio宣布董事会战略革新：引入四位资深商业领袖加速增长并推动盈利进程，同时公布2026年第一季度初步营收数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1110396189","media":"美股速递","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110396189?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:44","pubTimestamp":1777581859,"startTime":"0","endTime":"0","summary":"TELA Bio公司今日宣布对其董事会进行战略性革新，新引入四位拥有丰富行业经验的商业领袖。这一举措旨在加速公司业务增长，并推动实现盈利目标的战略路径。与此同时，该公司同步披露了2026年第一季度的初步营收业绩。此次董事会成员调整凸显了TELA Bio强化商业运营能力的决心。在公布董事会变动之际，TELA Bio还提前释放了2026年第一季度的营收信号。董事会焕新与营收数据公布的双重消息，标志着TELA Bio正积极推动企业发展的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","MDXG","BVS","ELUT","BK4198","AXGN","ANIK","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518726302","title":"Elutia, Inc.盘中异动 急速下跌8.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518726302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518726302?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:48","pubTimestamp":1741621699,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时48分，Elutia, Inc.股票出现波动，股价急速下跌8.47%。Elutia, Inc.股票所在的医疗器械行业中，整体跌幅为1.19%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023481998a2baf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023481998a2baf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518281646","title":"Elutia, Inc.2024财年实现净利润-54.13百万美元，同比减少31.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518281646?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536079,"startTime":"0","endTime":"0","summary":"3月10日，Elutia, Inc.公布财报，公告显示公司2024财年净利润为-54.13百万美元，同比减少31.22%；其中营业收入为24.38百万美元，同比减少1.49%，每股基本收益为-1.86美元。从资产负债表来看，Elutia, Inc.总负债82.39百万美元，其中短期债务6.11百万美元，资产负债比为0.44，流动比率为0.70。机构评级：截至2025年3月10日，当前有2家机构对Elutia, Inc.目标价做出预测，其中目标均价为9.00美元，其中最低目标价为8.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000254abf17582&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000254abf17582&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193158117","title":"Elutia第四季度GAAP每股收益$(0.26)未达到$(0.25)的预期，销售额$547万未达到$590万的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1193158117","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193158117?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:26","pubTimestamp":1741296410,"startTime":"0","endTime":"0","summary":"Elutia报告季度每股亏损$，未达到分析师一致预期的$，相差4%。这比去年同期$588万的销售额下降了6.93%。以上内容来自Benzinga Earnings专栏，原文如下：$Elutia$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 4 percent. This is a 60.61 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $5.47 million which missed the analyst consensus estimate of $5.90 million by 7.32 percent.  This is a 6.93 percent decrease over sales of $5.88 million the same pe","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Elutia第四季度GAAP每股收益$(0.26)未达到$(0.25)的预期，销售额$547万未达到$590万的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517929767","title":"Elutia, Inc.盘中异动 临近收盘股价大跌6.76%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517929767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517929767?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:58","pubTimestamp":1741208331,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时58分，Elutia, Inc.股票出现波动，股价急速跳水6.76%。截至发稿，该股报2.76美元/股，成交量2.3955万股，换手率0.06%，振幅6.76%。Elutia, Inc.股票所在的医疗器械行业中，整体涨幅为1.01%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045851a26132b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045851a26132b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517260919","title":"Elutia, Inc.盘中异动 股价大跌6.05%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517260919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517260919?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:28","pubTimestamp":1741105688,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时28分，Elutia, Inc.股票出现波动，股价快速下挫6.05%。截至发稿，该股报2.95美元/股，成交量5496股，换手率0.01%，振幅5.10%。Elutia, Inc.股票所在的医疗器械行业中，整体跌幅为0.97%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305002808abe80f65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305002808abe80f65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514674958","title":"Elutia, Inc.盘中异动 临近收盘股价大涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514674958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514674958?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:47","pubTimestamp":1740602839,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时47分，Elutia, Inc.股票出现波动，股价急速上涨7.14%。截至发稿，该股报3.45美元/股，成交量1.6113万股，换手率0.04%，振幅5.90%。Elutia, Inc.股票所在的医疗器械行业中，整体涨幅为0.75%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227044719abde3e09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227044719abde3e09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512480341","title":"Elutia, Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512480341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512480341?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:27","pubTimestamp":1739986062,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时27分，Elutia, Inc.股票出现异动，股价大幅拉升5.24%。Elutia, Inc.股票所在的医疗器械行业中，整体涨幅为0.55%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200127439628e9d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200127439628e9d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166426","title":"Elutia, Inc.盘中异动 急速拉升6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166426?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:51","pubTimestamp":1739890298,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时51分，Elutia, Inc.股票出现异动，股价快速上涨6.03%。Elutia, Inc.股票所在的医疗器械行业中，整体跌幅为0.69%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225139a24ab14f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225139a24ab14f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511585499","title":"Elutia, Inc.盘中异动 下午盘股价大涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511585499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511585499?lang=zh_cn&edition=full","pubTime":"2025-02-13 02:27","pubTimestamp":1739384850,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日02时27分，Elutia, Inc.股票出现异动，股价快速上涨5.68%。截至发稿，该股报2.81美元/股，成交量2.4209万股，换手率0.06%，振幅8.27%。Elutia, Inc.股票所在的医疗器械行业中，整体跌幅为0.63%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021302273298830f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021302273298830f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380867","title":"Elutia, Inc.盘中异动 股价大涨5.88%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380867?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284562,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，Elutia, Inc.股票出现异动，股价急速上涨5.88%。截至发稿，该股报2.70美元/股，成交量1223股，换手率0.00%，振幅4.51%。Elutia, Inc.股票所在的医疗器械行业中，整体跌幅为0.17%。其相关个股中，Lifeward Ltd.、Inspira Technologies Oxy B.H.N. Ltd.、Beyond Air, Inc.涨幅较大，Inspira Technologies Oxy B.H.N. Ltd.、Lifeward Ltd.、Beyond Air, Inc.较为活跃，换手率分别为55.07%、12.38%、2.17%，振幅较大的相关个股有Lifeward Ltd.、Hyperfine, Inc.、Biosig Technologies, Inc.，振幅分别为18.18%、15.95%、13.70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223602abcb0729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223602abcb0729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510897037","title":"Elutia, Inc.盘中异动 临近收盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510897037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510897037?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:00","pubTimestamp":1739221247,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日05时00分，Elutia, Inc.股票出现波动，股价快速下挫5.41%。截至发稿，该股报2.54美元/股，成交量1.7859万股，换手率0.04%，振幅6.04%。Elutia, Inc.股票所在的医疗器械行业中，整体涨幅为0.44%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211050047961e47fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211050047961e47fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509208243","title":"Elutia, Inc.盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509208243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509208243?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:40","pubTimestamp":1738856449,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时40分，Elutia, Inc.股票出现波动，股价急速上涨5.88%。Elutia, Inc.股票所在的医疗器械行业中，整体跌幅为0.24%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234049987c9a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234049987c9a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508114966","title":"Elutia, Inc.盘中异动 大幅下挫6.83%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508114966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508114966?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593197,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Elutia, Inc.股票出现波动，股价快速跳水6.83%。Elutia, Inc.股票所在的医疗器械行业中，整体跌幅为0.52%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223317abc1074e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223317abc1074e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELUT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507796106","title":"Elutia, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507796106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507796106?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:37","pubTimestamp":1738337840,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时37分，Elutia, Inc.股票出现波动，股价急速拉升5.16%。Elutia, Inc.股票所在的医疗器械行业中，整体涨幅为0.49%。Elutia, Inc.公司简介：Elutia Inc 前身为 Aziyo Biologics Inc，是一家商业阶段的再生医学公司，专注于创造下一代差异化产品并改善接受外科手术的患者的结果，并重点关注接受植入式医疗设备的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233720abbe47c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233720abbe47c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELUT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.elutia.com","stockEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":-0.0098},{"period":"3month","weight":-0.1562},{"period":"6month","weight":-0.25},{"period":"1year","weight":-0.3817},{"period":"ytd","weight":0.1693}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Elutia Inc.于2015年8月在特拉华州注册成立。该公司开发专有的药物洗脱生物基质产品，用于手术重建和相关应用。这些产品旨在改善植入医疗设备与患者之间的互动。该公司的重点是解决未满足的医疗需求并减少与手术相关的并发症，包括感染、迁移、糜烂、植入物排斥和纤维化。该公司的运营通过用于整形和重建手术的生物基质产品的商业分销跨越研发。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.215075},{"month":2,"riseRate":0.666667,"avgChangeRate":0.038255},{"month":3,"riseRate":0,"avgChangeRate":-0.238554},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.007228},{"month":5,"riseRate":0.666667,"avgChangeRate":0.051816},{"month":6,"riseRate":0.666667,"avgChangeRate":0.085217},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.105097},{"month":8,"riseRate":0.666667,"avgChangeRate":0.004878},{"month":9,"riseRate":0,"avgChangeRate":-0.16004},{"month":10,"riseRate":0.4,"avgChangeRate":-0.070896},{"month":11,"riseRate":0.5,"avgChangeRate":0.085577},{"month":12,"riseRate":0.5,"avgChangeRate":0.010593}],"exchange":"NASDAQ","name":"Elutia","nameEN":"Elutia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Elutia(ELUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Elutia(ELUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Elutia,ELUT,Elutia股票,Elutia股票老虎,Elutia股票老虎国际,Elutia行情,Elutia股票行情,Elutia股价,Elutia股市,Elutia股票价格,Elutia股票交易,Elutia股票购买,Elutia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Elutia(ELUT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Elutia(ELUT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}